Postow, Merea, named to new positions at MSK

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Michael Postow was named chief of the Melanoma Service in the Division of Solid Tumor Oncology, and Valeria Silva Merea was named director of the Speech and Hearing Center at Memorial Hospital and the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center.

Postow assumed his new role May 24. As chief of the Melanoma Service, he will oversee the ongoing strategic goals of the Melanoma Service to expand the clinical and research programs and activities in melanoma.

Valeria Silva Merea, a surgeon who specializes in caring for people with early laryngeal cancer, and voice, airway, and swallowing disorders, assumed her role in January 2020. She will expand clinical services and MSK’s research program for patients with the full spectrum of speech, voice, airway, swallowing, and hearing disorders.

Table of Contents

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login